行情

PTN

PTN

Palatin科技
AMEX

实时行情|Nasdaq Last Sale

0.4566
-0.0058
-1.25%
盘后: 0.4608 +0.0042 +0.92% 18:37 09/24 EDT
开盘
0.4504
昨收
0.4624
最高
0.4690
最低
0.4500
成交量
38.96万
成交额
--
52周最高
1.300
52周最低
0.3750
市值
1.05亿
市盈率(TTM)
-4.0018
分时
5日
1月
3月
1年
5年
Palatin 将报告 2021 年第四季度和财政年度的结果；电话会议和网络直播将于 2021 年 9 月 29 日举行
Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2021 operating results on Wednesday, September 29, 2021, before the open of the U.S. financial markets.
PR Newswire · 20小时前
Palatin 将在 TIDES USA 会议上展示肽平台
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor systems, today announced a featu...
PR Newswire - PRF · 09/15 11:30
Palatin 将参加 HC Wainwright 第 23 届年度全球投资虚拟会议
Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor systems, today announced that Carl Spana, Ph.D.,...
PR Newswire · 09/13 11:00
Palatin 宣布在 Eyecelerator@ASCRS 会议上发表演讲
/PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system, today announced that , P...
PR Newswire - PRF · 07/22 21:28
Cathie Wood 的 ARK Innovation 在市场暴跌中上涨——这就是她的基金的运作方式
Concerns about the Delta variant and another round of economic shutdowns could be scaring investors back into Wood's pandemic-proof stocks.
CNBC.com · 07/19 18:29
帕拉丁宣布休会年度股东大会
/PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN) announced that its 2021 Annual Meeting of Stockholders that convened on and was adjourned to , has been adjourned until at to allow Palatin to solicit additional proxies for Pro...
PR Newswire - PRF · 07/08 20:15
考虑购买 ContextLogic、Orphazyme、Marin Software、Xpeng 或 Palatin Technologies 的股票？
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WISH, ORPH, MRIN, XPEV, and PTN.
PR Newswire - PRF · 06/29 14:45
Palatin Technologies 公布干眼症治疗计划后股价走高
Benzinga · 06/29 13:18
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解PTN最新的财务预测，通过PTN每股收益，每股净资产，每股现金流等数据分析Palatin科技近期的经营情况，然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

强力推荐

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

目标价格预测
分析师预测PTN价格均价为2.333，最高价位3.000，最低价为2.000。
EPS
机构持股
总机构数: 98
机构持股: 4,469.12万
持股比例: 19.42%
总股本: 2.30亿
类型机构数股数
增持
32
480.92万
建仓
20
135.83万
减持
17
134.26万
平仓
6
112.48万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-2.13%
制药与医学研究
-1.02%
高管信息
Non-Executive Chairman/Independent Director
John Prendergast
President/Chief Executive Officer/Director
Carl Spana
Chief Financial Officer/Chief Operating Officer/Executive Vice President/Treasurer/Secretary
Stephen Wills
Independent Director
Robert deVeer
Independent Director
Alan Dunton
Independent Director
Joseph Hull
Independent Director
Anthony Manning
Independent Director
Arlene Morris
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
PTN 简况
Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. The melanocortin receptor (MCr) system is hormone driven, with effects on food intake, metabolism, sexual function, inflammation and immune system responses. There are five melanocortin receptors, MC1r through MC5r. The natriuretic peptide receptor (NPR) system regulates cardiovascular functions, and therapeutic agents modulating this system have potential to treat fibrotic diseases, cardiovascular diseases, including reducing cardiac hypertrophy and fibrosis, heart failure, acute asthma, pulmonary diseases and hypertension.

微牛提供Palatin Technologies, Inc.(AMEX-PTN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的PTN股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易PTN股票基本功能。